When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational Study
暂无分享,去创建一个
J. Robins | M. Hernán | S. Hernández-Díaz | J. Sterne | M. Egger | C. Sabin | S. Boswell | A. Phillips | P. Reiss | M. Mugavero | M. Saag | F. Dabis | D. Costagliola | A. Justice | S. Deeks | G. Seage | L. Meyer | G. Touloumi | A. van Sighem | J. Eron | F. Bonnet | H. Bucher | W. Mathews | S. Moreno | E. Ferrer | S. Abgrall | R. Muga | S. Napravnik | J. Del Amo | R. Logan | J. Tate | S. Jose | R. Seng | L. E. Cain | D. Drozd | E. Caniglia | A. Olson | Richard Moore
[1] J. Fleishman,et al. Retention in Care Is More Strongly Associated With Viral Suppression in HIV-Infected Patients With Lower Versus Higher CD4 Counts , 2014, Journal of acquired immune deficiency syndromes.
[2] A. Walker,et al. Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial , 2013, The Lancet.
[3] Arrow trial team. Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial , 2013 .
[4] P. Keiser,et al. A Model for Reduced HIV-1 Viral Load Monitoring in Resource-Limited Settings , 2013, Journal of the International Association of Providers of AIDS Care.
[5] C. Sabin,et al. British HIV Association guidelines for the routine investigation and monitoring of adult HIV‐1‐infected individuals 2011 , 2012, HIV medicine.
[6] Richard Degerman,et al. Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial , 2011, BMJ : British Medical Journal.
[7] Richard L. Degerman,et al. CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study , 2011, BMJ : British Medical Journal.
[8] E. Delaporte,et al. Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial. , 2011, The Lancet. Infectious diseases.
[9] James M Robins,et al. When to Initiate Combined Antiretroviral Therapy to Reduce Mortality and AIDS-Defining Illness in HIV-Infected Persons in Developed Countries , 2011, Annals of Internal Medicine.
[10] R. Chaiwarith,et al. Impact of the frequency of plasma HIV-1 RNA monitoring on the outcome of antiretroviral therapy. , 2011, Current HIV research.
[11] L. Chang,et al. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings. , 2010, The Cochrane database of systematic reviews.
[12] James M. Robins,et al. The International Journal of Biostatistics CAUSAL INFERENCE When to Start Treatment ? A Systematic Approach to the Comparison of Dynamic Regimes Using Observational Data , 2011 .
[13] A. Breckenridge,et al. Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial , 2010, The Lancet.
[14] James M Robins,et al. The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals , 2010, AIDS.
[15] B. Gazzard,et al. Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure? , 2008, AIDS.
[16] Richard D Moore,et al. Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems. , 2008, International journal of epidemiology.
[17] Hansjakob Furrer,et al. Self-Reported Non-Adherence to Antiretroviral Therapy Repeatedly assessed by Two Questions Predicts Treatment Failure in Virologically Suppressed Patients , 2008, Antiviral therapy.
[18] J. Robins,et al. Comparison of dynamic treatment regimes via inverse probability weighting. , 2006, Basic & clinical pharmacology & toxicology.
[19] Robert Oelrichs,et al. Monitoring of human immunodeficiency virus infection in resource-constrained countries. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] R. Haubrich,et al. A randomized study of the utility of human immunodeficiency virus RNA measurement for the management of antiretroviral therapy. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] John W. Ward,et al. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. , 1993, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[22] N. Ford,et al. HIV viral load monitoring in resource-limited regions: optional or necessary? , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.